aldosterone has been researched along with exenatide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Malendowicz, LK; Nowak, KW; Nussdorfer, GG; Tortorella, C; Trejter, M; Ziolkowska, A | 1 |
Malendowicz, LK; Neri, G; Nowak, KW; Nussdorfer, GG; Ziolkowska, A; Zyterska, A | 1 |
Heinla, K; Sedman, T; Vasar, E; Volke, V | 1 |
3 other study(ies) available for aldosterone and exenatide
Article | Year |
---|---|
Exendin-4, a GLP-1 receptor agonist, stimulates pituitary-adrenocortical axis in the rat: Investigations into the mechanism(s) underlying Ex4 effect.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Animals; Arginine Vasopressin; Corticosterone; Corticotropin-Releasing Hormone; Dexamethasone; Dose-Response Relationship, Drug; Exenatide; Female; Glucagon-Like Peptide-1 Receptor; Hormone Antagonists; Peptides; Pituitary-Adrenal System; Rats; Rats, Wistar; Receptors, Glucagon; Time Factors; Venoms | 2003 |
Prolonged exendin-4 administration stimulates pituitary-adrenocortical axis of normal and streptozotocin-induced diabetic rats.
Topics: Adrenocorticotropic Hormone; Aldosterone; Animals; Corticosterone; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Exenatide; Female; Glucagon-Like Peptide-1 Receptor; Peptides; Pituitary-Adrenal System; Rats; Rats, Wistar; Receptors, Glucagon; Streptozocin; Time Factors; Venoms | 2003 |
A GLP-1 Receptor Agonist Inhibits Aldosterone Release in Healthy Volunteers.
Topics: Adolescent; Adult; Aldosterone; Exenatide; Female; Follow-Up Studies; Glucagon-Like Peptide-1 Receptor; Healthy Volunteers; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Pituitary-Adrenal System; Young Adult | 2021 |